Voicemed

Early detection of COPD with acoustic analysis

VoiceMed Check for COPD is a smartphone-based test that analyses voice and breathing sounds with AI to detect signs of Chronic Obstructive Pulmonary Disease (COPD) in under a minute, without any external device or clinical visit.

COPD goes undiagnosed

Why COPD stays underdiagnosed

  • Symptoms are often normalized by patients
  • Spirometry is underused in primary care, GP time is limited
  • Specialist visit waiting time can be 6 months, meanwhile patient may be treated empirically
The impact
  • 50–90% of COPD cases still remain undiagnosed
  • 52% are diagnosed at later stage (GOLD stage 2)
  • 21% of hospitalization for COPD exacerbation are from underdiagnosed people

480M

Diagnosed patients

50–90%

Undiagnosed population

21.9%

Of hospitalization for exacerbation were of undiagnosed patients

Welcome VoiceMed Check for COPD

A simple, guided test to analyse signs of COPD for case finding, that anyone can complete in a minute, using its own smartphone and voice

Breathe and speak

Perform three deep breaths and a short vocalization (“aaah”).

Anywhere, anytime​

Take the test at home, with your own smartphone, no other devices required.

Get an instant result

Receive a clear indication in seconds, helping you understand whether to seek further evaluation.

Validated in clinical studies

The test captures voice and breathing sounds and analyse their acoustic characteristics, such as intensity, duration, and frequency patterns.
These signals are strongly correlated with airway obstruction compared to the COPD diagnosis made from the doctor and allow the system to identify whether a person has sign of of COPD and need a clinical visit.
This approach provides an objective signal based on real physiological data.

82.9%

Sensitivity

59.3%

Specificity​

55.6%

Positive Predictive Value

With 1,900+ patients

across a diverse population, including COPD, other respiratory conditions and healthy individuals. This is the biggest dataset of voice and respiratory diseases.

In clinical validation with:

Tested in pilots​​

“Through this collaboration, we aim to advance digital innovation to enable earlier detection and proactive, personalized management, helping to prevent exacerbations, keep patients stable at home, and improve quality of life in a more sustainable way.”

Michelle Soriano
Executive Vice President Air Franchise, Chiesi Group

Aiming at generating a positive impact

A simple, guided test that anyone can complete in under a minute, using just a smartphone

Improve diagnosis rates

Identify more at-risk individuals earlier and increase the number of patients entering the clinical pathway, reducing late-stage diagnosis.

Enable timely and appropriate treatment

Support earlier intervention and ensure patients receive the right treatment at the right time, improving disease management outcomes.

Expand access and health equity​​

Enable case-finding beyond clinical settings, reaching underserved and remote populations and reducing disparities in access to care.

How VoiceMed Check fits into your clinical workflow

A simple flow for COPD case finding. It is designed to integrate seamlessly into existing care pathways, from first contact to specialist referral

Identify at-risk patients​

Target individuals in primary care, pharmacies, or remote settings

Invite them to take the test​

Patients complete a guided test using their own smartphone

Receive an instant indication

Results are available in seconds, helping assess whether COPD may be present

Refer for clinical confirmation​​

If needed, patients can be directed to your specialists for spirometry and diagnosis

Easy to integrate, secure, and on the regulatory pathway

SDK & API 
integration

Test accessible through our app or by integrating it into third party app with SDK / API on iOS and Android, typically completed in one day.

GDPR-compliant and securely hosted in Europe

All data is handled in full compliance with GDPR requirements and securely hosted on European infrastructure.

Medical device 
pathway

Our software is being developed as a Class IIa medical device under the European MDR framework, with certification underway.

Interested in VoiceMed Check for COPD?

  • Partner with us today by doing a pilot test
  • Get early access to our product once it receives the MDR certification, by getting a personalised quote, with special partner positions signed in a letter of intent 
  • Contribute to expanding our clinical validation across new populations and settings